Skip to main content
Molecular Imaging and Radionuclide Therapy logoLink to Molecular Imaging and Radionuclide Therapy
. 2020 Apr 29;29(2):85–87. doi: 10.4274/mirt.galenos.2019.42104

Lymphoblastic Involvement of the Bone Marrow as a Cause of Superscan Appearance in 18F-Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography

18F-Florodeoksiglikoz Pozitron Emisyon Tomografisi/Bilgisayarlı Tomografi’de Supersken Görünümünün Bir Nedeni Olarak Kemik İliğinin Lenfoblastik Tutulumu

Zehra Pınar Koç 1,*, Pelin Özcan Kara 1, Aydan Akdeniz 2, Mehmet Yaldız 3
PMCID: PMC7201432  PMID: 32368881

Abstract

The 18F-fluorodeoxylucose (FDG) positron emission tomography (PET) is the gold standard imaging modality in the staging of lymphoma. The superscan appearance in the FDG PET/computerized tomography (CT) imaging might be because of benign diseases or malignant infiltrations. This case report presents lymphomatous blastic infiltration as a cause of superscan appearance in 18F-FDG PET/CT.

Keywords: Superscan, FDG, PET/CT, lymphoma

Figure 1.

Figure 1

Multiple intensity projection image of the fluorodeoxylucose (FDG) positron emission tomograph/computerized tomography (PET/CT) demonstrating significant uptake in bone marrow, spleen and lymph nodes and faint physiological activity in brain and liver without other soft tissue. Fifty-four-year-old female patient presented with anemia, leukopenia and trombositopenia. The patient was referred for 18F-FDG PET/CT imaging and bone marrow biopsy procedure. The PET/CT imaging was performed after a fasting period of 12 hours and the blood glucose level was 111 mg/dL. The imaging was performed 60 minutes after intravenous administration of 7.7 mCi 18F-FDG in craniocaudal direction in 3D acquisition mode for 1 min per bed position with nondiagnostic CT scan for attenuation correction with oral contrast administration. The imaging revealed multiple servical, mediastinal, abdominal lymph nodes and severe bone marrow activity accumulations suggesting the infiltration of the disease as well as diminished activity in the soft tissues, physiological uptake in the brain, liver and spleen (Figure 1).

Figure 2.

Figure 2

Pathology images of bone marrow biopsy show bone marrow infiltration of lymphoblastic cells with hematoxylene and eosine (left) and CD20 staining (right). The bone marrow biopsy revealed complete blastic (100%) infiltration of the bone marrow (Figure 2) and diagnosis of B cell lymphoma. The superscan imaging examples in the literature were usually due to the malignant tumor infiltration of the bone marrow or hepatic infiltration. According to a review analysis, the possible causes of superscan appearance in the FDG PET/CT imaging of the bone marrow might be due to the benign and malignant pathologies including the colony stimulating factors, pyrexia due to infection, primary or secondary hyperparathyroidism (1). Additionally, diffuse hepatic activity as a consequence of hepatic superscan in the FDG PET/CT was reported in the hepatic lymphoma (2) and hepatic angiosarcoma (3), previously. The superscan appearance obscures some findings and this causes false negative misinterpretation of some of the malignant lesions as well. There were two previously reported cases with diffuse large B cell lymphoma infiltration of the liver (4,5). These cases had significantly decreased physiologic uptake in the brain, cardiac and renal tissues as well. Parida et al. (6) reported a case with superscan acute lymphoblastic lymphoma with slight physiological uptakes in liver and spleen. This present case showed significant increased activity in bone marrow and spleen and superscan appearance as a result of malignant infiltration of “acute lymphoblastic lymphoma” of the tissues which was documented by bone marrow biopsy results.

Footnotes

Ethics

Informed Consent: Consent form was filled out by all participants.

Peer-review: Externally and internally peer-reviewed.

Authorship Contributions

Surgical and Medical Practices: Z.P.K., P.Ö.K., A.A., M.Y., Concept: Z.P.K., P.Ö.K., Design: Z.P.K., P.Ö.K., Data Collection or Processing: Z.P.K., P.Ö.K., A.A., M.Y., Analysis or Interpretation: Z.P.K., P.Ö.K., Literature Search: Z.P.K., P.Ö.K., Writing: Z.P.K., P.Ö.K., A.A., M.Y.

Conflict of Interest: No conflict of interest was declared by the authors.

Financial Disclosure: The authors declared that this study received no financial support.

References

  • 1.Manov JJ, Roth PJ, Kuker R. Clinical Pearls: Etiologies of Superscan Appearance on Fluorine-18-Fludeoxyglucose Positron Emission Tomography-Computed Tomography. Indian J Nucl Med. 2017;32:259–265. doi: 10.4103/ijnm.IJNM_56_17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kaneko K, Nishie A, Arima F, Yoshida T, Ono K, Omagari J, Honda H. A case of diffuse-type primary hepatic lymphoma mimicking diffuse hepatocellular carcinoma. Ann Nucl Med. 2011;25:303–307. doi: 10.1007/s12149-010-0460-0. [DOI] [PubMed] [Google Scholar]
  • 3.Oe A, Habu D, Kawabe J, Torii K, Kawamura E, Kotani J, Hayashi T, Sakaguchi H, Shiomi S. A case of diffuse hepatic angiosarcoma diagnosed by FDG-PET. Ann Nucl Med. 2005;19:519–521. doi: 10.1007/BF02985582. [DOI] [PubMed] [Google Scholar]
  • 4.Taneja S, Achong DM. Hepatic superscan on PET/CT due to Richter’s transformation of chronic lymphocytic leukemia. Clin Nucl Med. 2010;35:644–645. doi: 10.1097/RLU.0b013e3181e4dcad. [DOI] [PubMed] [Google Scholar]
  • 5.Yang G, Nie P, Wang Z, Xing X. (18)F-FDG hepatic superscan caused by a non-germinal center subtype of diffuse large B-cell lymphoma. Eur J Nucl Med Mol Imaging. 2016;43:1928. doi: 10.1007/s00259-016-3399-0. [DOI] [PubMed] [Google Scholar]
  • 6.Parida GK, Soundararajan R, Passah A, Bal C, Kumar R. Metabolic Skeletal Superscan on 18F-FDG PET/CT in a Case of Acute Lymphoblastic Leukemia. Clin Nucl Med. 2015;40:567–568. doi: 10.1097/RLU.0000000000000785. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Imaging and Radionuclide Therapy are provided here courtesy of Galenos Yayinevi

RESOURCES